DailyDoctor Archive Specialties Get app
Back to the 2 September 2026 edition

Research · 03 of 05

Acetate-buffered fluid did not beat Ringer's for post-ERCP pancreatitis

Acetate-buffered crystalloid did not reduce post-ERCP pancreatitis compared with lactated Ringer's, and a symptom-guided four-hour hydration protocol sufficed for two-thirds of patients.

A multicentre double-blind superiority trial at three Korean academic hospitals randomised 813 adults with native papillae and moderate-to-high risk of post-ERCP pancreatitis to lactated Ringer's or an acetate-buffered balanced crystalloid. Rectal NSAIDs are unavailable in this setting, which makes fluid the primary preventive strategy rather than an adjunct.

The protocol is worth noting on its own: 10 mL/kg boluses before and after ERCP, then 3 mL/kg/h for four hours, extended to eight only if abdominal pain developed or worsened. That symptom-guided design addresses the practical objection to the standard eight-hour protocol, which is unworkable in an outpatient list.

Pancreatitis occurred in 12.4% with Ringer's and 11.5% with acetate, a relative risk of 0.93 with an interval from 0.64 to 1.35. Mild and moderate rates were similar; no severe pancreatitis and no fluid overload occurred in either arm.

The incidental finding may be the more useful one. Of the 68.3% of patients still asymptomatic at four hours who therefore received only the shortened protocol, pancreatitis occurred in 7.4% with no severe cases — which suggests two-thirds of patients can leave after four hours of hydration rather than eight.

  • Ringer's remains first line; acetate offers no advantage
  • Specific to settings without rectal NSAIDs, which are first line where available
  • The symptom-guided 4-hour protocol let 68% stop at four hours
  • Those shortened-protocol patients had 7.4% pancreatitis and no severe cases
  • No fluid overload in either arm despite aggressive hydration

The statistics, in plain English

This was a superiority trial, so a relative risk of 0.93 with an interval from 0.64 to 1.35 means superiority was not shown — not that the two fluids are equivalent, which would require a non-inferiority design with a prespecified margin. The practical conclusion, that Ringer's remains first line, follows from it being the established option rather than from the acetate arm being worse.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

cirrhosismasldviralheppancreasendoscopyibdfunctional

Tomorrow morning, before your first patient

One edition a day for gastroenterology & hepatology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app